Aniplus Inc. (KOSDAQ:310200)
3,060.00
+35.00 (1.16%)
At close: Jan 29, 2026
Aniplus Market Cap
Aniplus has a market cap or net worth of 155.41 billion as of January 30, 2026. Its market cap has increased by 35.68% in one year.
Market Cap
155.41B
Enterprise Value
164.27B
Revenue
146.00B
Ranking
n/a
PE Ratio
6.24
Stock Price
3,060.00
Market Cap Chart
Since January 22, 2020, Aniplus's market cap has increased from 6.16B to 155.41B, an increase of 2,422.55%. That is a compound annual growth rate of 70.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 153.64B | -10.24% |
| Dec 30, 2025 | 171.16B | 49.42% |
| Dec 30, 2024 | 114.55B | -21.62% |
| Dec 28, 2023 | 146.14B | -24.07% |
| Dec 29, 2022 | 192.47B | 30.83% |
| Dec 30, 2021 | 147.12B | 242.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WSI Co., Ltd. | 154.42B |
| EXEM Co., Ltd. | 154.00B |
| Kyung Dong Pharmaceutical | 153.57B |
| Atinum Investment | 153.44B |
| Samik Pharmaceutical Company LTD. | 153.21B |
| Kns Co., Ltd | 152.63B |
| DreamCIS | 152.32B |
| CG MedTech | 152.31B |